Balanced Perspective: Conditional Game Changer The evidence suggests that GLP-1 agonists represent a conditional game changertransformative for appropriate patients with adequate access and support, but with significant limitations that prevent universal application
Commonly reported side effects (incidence 5%) include: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, low blood sugar, heartburn, fatigue (sleepiness), dizziness, stomach-area pain, increased lipase (a pancreatic enzyme), upper stomach-area pain, fever, and stomach infection (gastroenteritis)
Evidence from German clinical practice in an IQVIA study underscores this gap: BMI documentation was recorded for only 10.8% of patients [2] highlighting that comprehensive measurements of obesity are not being translated to clinical practice
[7] [8] It is available via NHS Talking Therapies and through NICE-recommended digital CBT-I programmes (availability may vary by area your GP can advise on local options)
Epithalon Epithalon is a synthetic tetrapeptide that mimics epithalamin, a natural peptide produced by the pineal gland
General health status matters for risk tolerance
